Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Kidney Journal|February 22, 2020
Hard water syndrome: a case series of 30 patients from a London haemodialysis unitHugh Leonard, Taryn Pile
Current Treatment Options in Oncology|April 14, 2023
New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE)Silvia Stacchiotti, William Tap, Hugh Leonard, et al.
Scientific Reports|May 12, 2021
Long-term kidney function of patients discharged from hospital after an intensive care admission: observational cohort studyRyan W Haines, Jonah Powell-Tuck, Hugh Leonard, et al.
BMJ Open|March 25, 2025
Identifying interventions to optimise advanced kidney care services: scoping review protocolRobert Kimmitt, Hugh Leonard, Oshini Shivakumar, et al.
Iscience|January 18, 2021
PAR-1 signaling on macrophages is required for effective in vivo delayed-type hypersensitivity responsesHannah Wilkinson, Hugh Leonard, Daxin Chen, et al.
Frontiers in Oncology|March 12, 2024
The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatmentsDenise Robinson, Hugh Leonard, Giacomo Giulio Baldi, et al.
European Journal of Cancer Care|May 14, 2021
Supportive care needs of patients living with an extremely rare and unpredictable cancer: The Epithelioid Haemangioendothelioma patient experienceOlga Husson, Marije Weidema, Hugh Leonard, et al.
Frontiers in Immunology|September 29, 2022
Manipulation of tissue factor-mediated basal PAR-2 signalling on macrophages determines sensitivity for IFNγ responsiveness and significantly modifies the phenotype of murine DTHHannah Wilkinson, Hugh Leonard, Michael G Robson, et al.
Acta Oncologica (Stockholm, Sweden)|June 2, 2020
Health-related quality of life and symptom burden of epithelioid hemangioendothelioma patients: a global patient-driven Facebook study in a very rare malignancyMarije E Weidema, Olga Husson, Winette T A van der Graaf, et al.
Journal of the American Heart Association|July 3, 2020
Regression of Atherosclerosis in ApoE-/- Mice Via Modulation of Monocyte Recruitment and Phenotype, Induced by Weekly Dosing of a Novel "Cytotopic" Anti-Thrombin Without Prolonged AnticoagulationDaxin Chen, Ke Li, Sam Festenstein, et al.
Pageof 2